These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23719439)

  • 1. Immunotherapy's cancer remit widens.
    Ledford H
    Nature; 2013 May; 497(7451):544. PubMed ID: 23719439
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monoclonal antibodies and chemotherapy: therapeutic indications].
    Carrozza F
    Suppl Tumori; 2004; 3(4):S127-9. PubMed ID: 15206238
    [No Abstract]   [Full Text] [Related]  

  • 3. American Association of Cancer Research Showcases Immunotherapy Advances.
    Brower V
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26243202
    [No Abstract]   [Full Text] [Related]  

  • 4. GlaxoSmithKline cancer drug threatens Herceptin market.
    Waltz E
    Nat Biotechnol; 2005 Dec; 23(12):1453-4. PubMed ID: 16333273
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cancer immunotherapy: recent breakthroughs and perspectives].
    Tartour E; Sandoval F; Bonnefoy JY; Fridman WH
    Med Sci (Paris); 2011 Oct; 27(10):833-41. PubMed ID: 22027420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies for medical oncology: a few critical perspectives.
    Belda-Iniesta C; Ibáñez de Cáceres I; de Castro J
    Clin Transl Oncol; 2011 Feb; 13(2):84-7. PubMed ID: 21324795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances and outlooks for immunotherapy of cancer.
    Steplewski Z
    Hybridoma; 1993 Oct; 12(5):493-500. PubMed ID: 8300120
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor immunology top 10 list.
    Finn OJ
    Immunol Rev; 2008 Apr; 222():5-8. PubMed ID: 18363991
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer.
    Zhang T; Herlyn D
    Cancer Immunol Immunother; 2009 Apr; 58(4):475-92. PubMed ID: 18925393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapies in clinical trials: do they demand different evaluation tools?
    Tuma RS
    J Natl Cancer Inst; 2011 May; 103(10):780-1. PubMed ID: 21551417
    [No Abstract]   [Full Text] [Related]  

  • 11. Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
    Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ
    Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rewarding value creation to promote innovation in oncology: The importance of considering the global product life cycle.
    Garrison LP
    Oncologist; 2010; 15 Suppl 1():49-57. PubMed ID: 20237218
    [No Abstract]   [Full Text] [Related]  

  • 13. From therapeutic monoclonal antibodies to therapeutic vaccines for cancer.
    Berinstein NL
    Hum Vaccin; 2009 Jun; 5(6):364-7. PubMed ID: 19694082
    [No Abstract]   [Full Text] [Related]  

  • 14. Deal watch: Bristol-Myers Squibb invests in cancer antibody that targets the innate immune system.
    Nat Rev Drug Discov; 2011 Aug; 10(9):648. PubMed ID: 21878969
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer immunology.
    Finn OJ
    N Engl J Med; 2008 Jun; 358(25):2704-15. PubMed ID: 18565863
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoclonal antibody therapy of cancer.
    DiMaggio JJ; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1990; 11():177-203. PubMed ID: 2223394
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiogenesis. A boost for tumor starvation.
    Marx J
    Science; 2003 Jul; 301(5632):452-4. PubMed ID: 12881543
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody-targeted immunotherapy for treatment of malignancy.
    White CA; Weaver RL; Grillo-López AJ
    Annu Rev Med; 2001; 52():125-45. PubMed ID: 11160771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoclonal antibodies and chemotherapy: planning and management of symptoms].
    Berardini R
    Suppl Tumori; 2004; 3(4):S130-2. PubMed ID: 15206239
    [No Abstract]   [Full Text] [Related]  

  • 20. Avastin-Tarceva combination fails in lung cancer.
    Jones D
    Nat Biotechnol; 2009 Feb; 27(2):108-9. PubMed ID: 19204674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.